CRYOPORT, INC. financials

CYRX CIK 0001124524

Source: EDGAR filings · Built 2026-06-02T02:47:46Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2020FY 2020
Free Cash Flow -25.43M -33.83M -39.69M -24.03M -15.81M -23.85M
EBITDA -9.09M -90.91M -73.05M -9.14M 2.42M -20.14M
Working Capital 257.16M 277.01M 489.50M 563.33M 650.87M 112.14M
Net Debt -19.78M 216.57M 380.81M 406.68M 287.95M 94.05M
Gross Margin 47.14% 44.43% 44.67% 43.78% 43.38% 46.17%
Operating Margin -20.89% -77.61% -59.61% -13.45% -8.01% -38.13%
Net Margin 44.44% -73.20% -59.05% -15.73% -123.77% -41.54%
Return on Equity (ROE) 15.58% -28.55% -20.36% -6.72% -42.93% -8.54%
Return on Assets (ROA) 10.24% -16.31% -10.40% -3.59% -24.76% -5.92%
Current Ratio 2.17× 5.29× 11.73× 14.79× 16.26× 4.20×
Debt-to-Equity 0.46× 0.62× 0.85× 0.78× 0.67× 0.34×
Effective Tax Rate -5.59% -0.34% -0.41% -6.38% -0.62% 0.14%
Cash Conversion Ratio -0.11× 0.14× 0.01× 0.05× -0.03× 0.45×
Accruals Ratio 0.11× -0.14× -0.10× -0.03× -0.25× -0.03×
SBC % of Revenue 5.71% 10.57% 11.75% 8.46% 6.89% 11.33%
CapEx Coverage -0.51× -0.93× -0.02× -0.08× 0.34× -1.65×
Free Cash Flow Per Share $-0.51 $-0.69 $-0.81 $-0.49 $-0.34 $-0.62

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2020FY 2020
P/E Trailing (Diluted) 6.86×
EV / EBITDA 1333.23×
P/S 2.72× 2.48× 4.50× 3.53× 13.19× 22.21×
P/B 0.95× 0.97× 1.55× 1.51× 4.57× 4.57×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2020FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 176.18M 156.77M 168.66M 237.28M
Revenues 176.18M 156.77M 168.66M 237.28M 222.61M 78.70M
Cost of Revenue 93.12M 87.11M 93.33M 133.40M 126.03M 42.36M
Gross Profit 83.05M 69.66M 75.33M 103.87M 96.58M 36.33M
Research and Development Expense 17.04M 17.71M 18.04M 15.72M 16.84M 9.48M
Selling, General and Administrative Expense 102.82M 109.81M 108.26M 120.06M 97.56M 56.86M
Operating Expenses 119.86M 191.33M 175.87M 135.78M 114.41M 66.34M
Operating Income (Loss) -36.81M -121.67M -100.54M -31.90M -17.83M -30.01M
Income Tax Expense (Benefit) 1.80M 359.00K 345.00K 2.24M 1.69M -45.00K
Net Income (Loss) Attributable to Parent 78.30M -114.76M -99.59M -37.33M -275.53M -32.69M
Earnings Per Share, Basic $1.40 $-2.49 $-2.21 $-0.93 $-6.18 $-1.94
Weighted Average Number of Shares Outstanding, Basic 50.07M 49.35M 48.74M 48.99M 45.93M 38.58M
Earnings Per Share, Diluted $1.40 $-2.49 $-2.21 $-0.93 $-6.18 $-1.94
Weighted Average Number of Shares Outstanding, Diluted 50.07M 49.35M 48.74M 48.99M 45.93M 38.58M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2020FY 2020
Cash and Cash Equivalents, at Carrying Value 250.49M 34.14M 35.19M 29.23M 139.10M 36.87M
Assets, Current 476.17M 341.57M 535.11M 604.18M 693.52M 147.16M
Assets 764.99M 703.49M 957.74M 1.04B 1.11B 552.40M
Liabilities, Current 219.02M 64.56M 45.61M 40.85M 42.65M 35.02M
Liabilities 262.35M 301.59M 468.72M 482.91M 471.14M 169.71M
Stockholders' Equity Attributable to Parent 502.64M 401.90M 489.02M 555.84M 641.83M 382.70M
Common Stock, Shares, Outstanding 49.85M 49.91M 48.97M 48.33M 49.62M 39.84M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2020FY 2020
Net Cash Provided by (Used in) Operating Activities -8.58M -16.32M -757.00K -1.85M 8.13M -14.87M
Payments to Acquire Property, Plant, and Equipment 16.44M 17.25M 38.78M 22.11M 23.88M 8.92M
Net Cash Provided by (Used in) Investing Activities 250.32M 176.81M 36.05M -59.68M -469.25M -382.31M
Payments for Repurchase of Common Stock 10.01M 37.96M 0 0
Net Cash Provided by (Used in) Financing Activities -21.07M -161.53M -23.80M -39.17M 564.34M 385.58M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CYRX CIK 0001124524), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

VOR

VOR BIOPHARMA INC.

DOV

DOVER Corp

NDSN

NORDSON CORPORATION